📖

ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 1

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-abcb1

Related Entities

Metadata

slug	genes-abcb1
entity_type	gene
kg_node_id	abcb1

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (647)

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming90%

mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming80%

mentions🔬What are the mechanisms underlying blood-brain barrier trans70%

mentions🧫s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice 70%

mentions🧫s:** - Compare uptake with/without magnetic particles using 70%

mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%

mentions🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka70%

mentions🧫Vascular Contribution to Alzheimer's Disease — Beyond A70%

mentions🧪LRP1-Dependent Tau Uptake Disruption70%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering70%

see_also🧪Synthetic Biology BBB Endothelial Cell Reprogramming70%

mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro65%

mentions🔬What are the mechanisms underlying blood-brain barrier trans63%

see_also📖DNA Methylation Biomarkers in Neurodegeneration60%

see_also📖Epigenetic Biomarkers in Neurodegenerative Diseases60%

see_also📖Tumor Necrosis Factor Alpha (TNF-α) as a Neurodegenerative D60%

see_also📖DNA Damage-Accumulating Neurons in Neurodegeneration60%

see_also📖DNA Damage and Repair in Neurons60%

see_also📖ATP P2X3 Receptor Neurons60%

see_also📖Parkinson Basal Ganglia Circuit60%

see_also📖DNA Damage Response in Corticobasal Syndrome60%

see_also📖Apoptosis in Neurodegeneration60%

see_also📖entities-tnf60%

see_also📖Tumor Necrosis Factor (TNF)60%

see_also📖DNA Damage Repair Deficiency Validation Study in Parkinson&#60%

see_also📖Epigenetic Clocks in Neurodegeneration — Causal Drivers or P60%

see_also📖Epigenetic Dysregulation in Huntington's Disease — Ther60%

see_also📖Epigenetic Dysregulation Validation in Parkinson's Dise60%

see_also📖Epigenetic Regulation Dysfunction in Alzheimer's and Pa60%

see_also📖Genes60%

see_also📖ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 260%

see_also📖app60%

see_also📖CAV160%

see_also📖JUN Gene60%

see_also📖KMT2A — lysine methyltransferase 2A60%

see_also📖LRP1 Gene60%

see_also📖MBD2 Gene - Methyl-CpG Binding Domain Protein 260%

see_also📖NEIL1 — Nei Endonuclease VIII-Like 160%

see_also📖NEIL2 — Nei Endonuclease VIII-Like 260%

see_also📖NEIL3 Gene60%

see_also📖TFR1 Gene60%

see_also📖TNF - Tumor Necrosis Factor60%

see_also📖YBX1 Gene60%

see_also📖DNA Damage Repair Deficiency Hypothesis in Parkinson's 60%

see_also📖Epigenetic Dysregulation Hypothesis in Parkinson's Dise60%

see_also📖Epigenetic-Metabolic Coupling: SIRT1 Activator + NAD+ Precur60%

see_also📖LRP1-Targeted ApoE-Mimetic Peptide Delivery60%

see_also📖DNA Damage Repair Therapy - Biomarker Guided60%

see_also📖APP Gene Dosage Reduction Therapy for Down Syndrome60%

see_also📖Epigenetic Clock Reversal Therapy for Neurodegeneration Prev60%

see_also📖LRP1-Enhanced Perivascular Drainage Therapy60%

see_also📖Packard Center for ALS Research60%

see_also📖Apoptosis Inhibitors for Neurodegeneration — Investment Land60%

see_also📖DNA Damage Repair Investment Landscape60%

see_also📖Epigenetic Therapy in Neurodegeneration: Investment Landscap60%

see_also📖MAPK Signaling Inhibitors: Investment Landscape Analysis60%

see_also📖Actin Cytoskeleton Dynamics in Neurodegeneration60%

see_also📖Epigenetic Alterations in Alzheimer's Disease60%

see_also📖Apoptosis Pathway in Neurodegeneration60%

see_also📖Apoptosis Pathways in Alzheimer's Disease60%

see_also📖Apoptosis in Neurodegeneration60%

see_also📖Apoptosis Pathways in Parkinson's Disease60%

see_also📖ER Stress and Unfolded Protein Response in Corticobasal Dege60%

see_also📖ER Stress in Corticobasal Syndrome60%

see_also📖ER Stress and Unfolded Protein Response in Corticobasal Dege60%

see_also📖DNA Damage Response in Alzheimer's Disease60%

see_also📖dna-damage-repair60%

see_also📖DNA Damage Repair Mechanisms Across Neurodegenerative Diseas60%

see_also📖DNA Damage Response Impairment Pathway60%

see_also📖DNA Damage Response in 4R-Tauopathies60%

see_also📖DNA Damage Response in Alzheimer's Disease60%

see_also📖DNA Damage Response in Corticobasal Syndrome60%

see_also📖DNA Damage Response and Repair in Neurodegeneration60%

see_also📖DNA Damage Response in Neurons60%

see_also📖DNA Damage Response in Parkinson's Disease60%

see_also📖DNA Damage Response in Neurodegeneration60%

see_also📖DNA Methylation in Neurodegeneration60%

see_also📖DNA Repair Mechanisms in Neurodegeneration60%

see_also📖DNA Sensing Pathways in Neurodegeneration60%

see_also📖Epigenetic Alterations in Alzheimer's Disease60%

see_also📖Epigenetic Clocks in Brain Aging60%

see_also📖Epigenetic Dysregulation Comparison Across Neurodegenerative60%

see_also📖Epigenetic Dysregulation in 4R-Tauopathies60%

see_also📖Epigenetic Dysregulation in Neurodegeneration60%

see_also📖Epigenetic Regulation60%

see_also📖Epigenetic Mechanisms in Alzheimer's Disease60%

see_also📖Epigenetic Changes in Progressive Supranuclear Palsy60%

see_also📖ER Stress and Unfolded Protein Response Pathway in Neurodege60%

see_also📖ER Stress and Unfolded Protein Response in 4R-Tauopathies60%

see_also📖ER Stress and UPR Disease Comparison60%

see_also📖ER Stress and Unfolded Protein Response in Neurodegeneration60%

see_also📖ER Stress and Unfolded Protein Response in Parkinson's 60%

see_also📖ER Stress and Unfolded Protein Response in Progressive Supra60%

see_also📖MAPK Signaling Pathways in Neurodegeneration60%

see_also📖Ras-MAPK Signaling Pathway in Neurodegeneration60%

see_also📖Tumor-Derived Cystatin C Enables Amyloid Clearance60%

see_also📖APP Protein60%

see_also📖MLL1 Histone H3K4 Methyltransferase (KMT2A)60%

see_also📖LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1)60%

see_also📖NEIL2 Protein60%

see_also📖DNA Damage Repair Therapy for Neurodegeneration60%

see_also📖DNA Repair Therapy for Neurodegeneration60%

see_also📖Epigenetic Reprogramming and Partial Reprogramming in Neurod60%

see_also📖Epigenetic Therapies for Neurodegeneration60%

see_also📖Epigenetic Therapies for Parkinson's Disease60%

see_also📖ER Stress and UPR Modulator Therapy for Neurodegeneration60%

see_also📖Aging-Associated Astrocytes60%

see_also📖Aging Microglia60%

see_also📖Aging Oligodendrocytes60%

see_also📖Cerebellar Granule Cells in Neurodegenerative Disease60%

see_also📖Cerebellar Neurons in Creutzfeldt-Jakob Disease60%

see_also📖Cerebellar Purkinje Cells60%

see_also📖Pedunculopontine Nucleus Cholinergic Neurons in Lewy Body Di60%

see_also📖Pedunculopontine Nucleus Neurons in Lewy Body Disease60%

see_also📖Spinal Cord Interneurons in Motor Neuron Disease60%

see_also📖diseases-motoneuron-disease60%

see_also📖ADRA2A Gene60%

see_also📖ADRB2 Gene60%

see_also📖BCHE Gene - Butyrylcholinesterase60%

see_also📖cct260%

see_also📖CHAT Gene60%

see_also📖COMT Gene60%

see_also📖COX15 — Cytochrome C Oxidase Assembly Factor 1560%

see_also📖CYP2D6 — Cytochrome P450 2D660%

see_also📖CYP3A4 — Cytochrome P450 3A460%

see_also📖DES Gene60%

see_also📖DOT1L Gene60%

see_also📖DRD2 Gene60%

see_also📖GABRA1 Gene60%

see_also📖GCH1 Gene60%

see_also📖GPNMB Gene60%

see_also📖GSTP1 — Glutathione S-Transferase Pi 160%

see_also📖gusb60%

see_also📖HMGCR — 3-Hydroxy-3-Methylglutaryl-CoA Reductase60%

see_also📖HTR2C Gene60%

see_also📖LRRK2 — Leucine Rich Repeat Kinase 260%

see_also📖MAOB Gene60%

see_also📖nbea60%

see_also📖NUCKS1 Gene60%

see_also📖OPRM1 — Mu-Opioid Receptor60%

see_also📖PARP1 Gene60%

see_also📖PEX3 Gene - Peroxisome Biogenesis Factor 360%

see_also📖PLCG2 Gene60%

see_also📖PPP1R7 — SDS22 (Protein Phosphatase 1 Regulatory Subunit 7)60%

see_also📖RPL4 — Ribosomal Protein L460%

see_also📖slc30a860%

see_also📖SLC6A2 — Norepinephrine Transporter60%

see_also📖SLC6A3 Gene60%

see_also📖SLC6A4 Gene — Serotonin Transporter60%

see_also📖SNCA — Alpha-Synuclein60%

see_also📖stathmin60%

see_also📖VPS16 Gene60%

see_also📖VPS33A Gene60%

see_also📖Alzheimer Indonesia60%

see_also📖aging-neurodegeneration60%

see_also📖Aging to AD Switch: Triggers60%

see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%

see_also📖Cerebrovascular Disease in Neurodegeneration60%

see_also📖cross-disease60%

see_also📖IVNS1ABP Mutation: Progeria-Like Disease with Neurological D60%

see_also📖Sphingolipid Metabolism in Neurodegeneration60%

see_also📖Sphingolipid Metabolism Dysregulation in 4R-Tauopathies60%

see_also📖Sphingolipid Metabolism in Neurodegeneration60%

see_also📖Sphingolipid Signaling Pathway in Neurodegeneration60%

see_also📖LRRK2 G2019S Transgenic Mouse Model60%

see_also📖COX15 Protein60%

see_also📖GSTP1 Protein (Glutathione S-Transferase Pi 1)60%

see_also📖LRRK2 (Leucine-Rich Repeat Kinase 2)60%

see_also📖Mu-Opioid Receptor Protein60%

see_also📖PARP1 (Poly(ADP-Ribose) Polymerase 1)60%

see_also📖stathmin60%

see_also📖Stathmin-1 Protein60%

see_also📖Stathmin-2 Protein60%

see_also📖Stathmin-2** is a protein. This page describes its structure60%

see_also📖VPS16 Protein60%

see_also📖chop60%

see_also📖CHOP Protein60%

see_also📖p38 MAPK Protein60%

see_also📖AQP4 (Aquaporin-4 Gene)60%

see_also📖CLDN5 — Claudin-560%

see_also📖LDLR Gene60%

see_also📖OCLN — Occludin60%

see_also📖Aquaporin-4 Protein60%

see_also📖PPAR (Peroxisome Proliferator-Activated Receptor)60%

see_also📖CHRNA7 Gene60%

see_also📖PPAR (Peroxisome Proliferator-Activated Receptor)60%

see_also📖Alpha-Synuclein Seed Kinetic Staging in Parkinson's Dis60%

see_also📖AT(N) Biomarker Classification for Alzheimer's Disease60%

see_also📖A/T/N+ Comprehensive Biomarker Panel for Alzheimer's Di60%

see_also📖Combination Biomarker Panels for Alzheimer's Disease60%

see_also📖Cholinergic Basal Forebrain Neurons in Alzheimer's Dise60%

see_also📖Cortical Layer 5 Pyramidal Neurons in Alzheimer's Disea60%

see_also📖Dentate Gyrus Granule Cells in Alzheimer's Disease60%

see_also📖Disease-Associated Microglia in Alzheimer's Disease60%

see_also📖dopaminergic-vta-pd60%

see_also📖Dorsal Raphe Serotonergic Neurons in Parkinson's Diseas60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Early Alzheimer's 60%

see_also📖Entorhinal Cortex Layer II Neurons in Alzheimer's Disea60%

see_also📖Globus Pallidus Internus in Parkinsons Disease60%

see_also📖Layer 2 Entorhinal Cortex Neurons in Alzheimer Disease60%

see_also📖Locus Coeruleus Noradrenergic Neurons in Alzheimer's Di60%

see_also📖Locus Coeruleus Norepinephrine in AD60%

see_also📖Melanocytes in Parkinson Disease60%

see_also📖Nigrostriatal Dopamine Terminals in Parkinson's Disease60%

see_also📖Dopaminergic Substantia Nigra Neurons in Parkinson's Di60%

see_also📖Temporal Cortex Neurons in Alzheimer's Disease60%

see_also📖Vulnerable Dopaminergic Neurons in Parkinson's Disease60%

see_also📖AB-1005 (REGENERATE-PD) GDNF Gene Therapy Trial60%

see_also📖ABBV-951 (foslevodopa/foscarbidopa) for Parkinson's Dis60%

see_also📖AMDX-2011P Phase 2 Trial for Alzheimer's Disease60%

see_also📖AMDX-2011P Retinal Amyloid Tracer in Alzheimer's Diseas60%

see_also📖Apocynin for Parkinson's Disease60%

see_also📖Bacillus Subtilis for Parkinson Disease (NCT06487975)60%

see_also📖Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT062260%

see_also📖biib122-luma-lrrk2-inhibitor-pd60%

see_also📖Bilingualism Cognitive Reserve AD Trial60%

see_also📖CT1-DAP001 iPS Cell-derived Dopaminergic Progenitors for Par60%

see_also📖CVN424 Phase 3 ARISE Trial for Parkinson's Disease60%

see_also📖Intranasal Insulin and Glutathione for PD (NOSE-PD)60%

see_also📖Lactococcus lactis CKDB001 for Alzheimer's Disease (NCT60%

see_also📖LY-3372689 MAGNOLIA Trial - Phase 2 in Alzheimer's Dise60%

see_also📖Methylphenidate + iTBS for Apathy in AD (PRIME Trial)60%

see_also📖MK-1167 Phase 2 Alzheimer's Disease Trial60%

see_also📖NCT05565443: MR-Guided Focused Ultrasound + GCase for Parkin60%

see_also📖Gabapentin Enacarbil Phase 4 Trial - Nighttime Agitation60%

see_also📖NCT04840979 - Genetic Variants Affecting Microglial Activati60%

see_also📖nct05266417-nose-pd60%

see_also📖nct06365190-rtms-pd60%

see_also📖NCT06487975: Bacillus Subtilis Gut Microbiome Intervention f60%

see_also📖Autologous Stem Cell-Derived Dopaminergic Neurons for Parkin60%

see_also📖Dyadic Mindfulness for PD Carers (NCT06821230)60%

see_also📖Amino Acid Supplement in Parkinson's Disease (NCT06954660%

see_also📖NCT07138677: MCI Network Guided TMS for Early Alzheimer'60%

see_also📖RO7812653 for Early Symptomatic Alzheimer's Disease60%

see_also📖Vibrotactile Stimulation Walking Speed PD Trial60%

see_also📖Noradrenergic Arousal System Phase 3 PD Trial (NCT07316296)60%

see_also📖tDCS + Nordic Walking for Parkinson's Disease Motor Sym60%

see_also📖NouvNeu001 Cell Therapy for Parkinson's Disease60%

see_also📖PDE4 Inhibitor PD Trial60%

see_also📖Retigabine PD Trial60%

see_also📖TTYP01 Phase 2 Alzheimer's Disease Trial60%

see_also📖Valacyclovir for HSV-1-Positive Parkinson's Disease60%

see_also📖NCT05881460: Vibrotactile Coordinated Reset for Parkinson&#x60%

see_also📖XTR006 Tau PET for Alzheimer's Disease (NCT07115238)60%

see_also📖Accelerating Medicines Partnership Alzheimer's Disease 60%

see_also📖AMP-PD: Accelerating Medicines Partnership: Parkinson's60%

see_also📖Neurodegeneration60%

see_also📖Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%

see_also📖Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%

see_also📖Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%

see_also📖Experiment: Autoimmune Hypothesis Testing in AD60%

see_also📖Experimental: CAAR-T Cell Therapy for Autoantibody-Mediated 60%

see_also📖Combination Therapy Sequencing in Parkinson's Disease60%

see_also📖Selective Vulnerability of Dopaminergic Neurons — Mechanism 60%

see_also📖GLP-1 Agonist Responder Prediction Study — Precision Medicin60%

see_also📖Non-Motor Symptom Progression in Parkinson's Disease — 60%

see_also📖SCFA-Mediated Neuroinflammation in Alzheimer's Disease60%

see_also📖Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%

see_also📖Accelerating Medicines Partnership for Alzheimer's Dise60%

see_also📖Accelerating Medicines Partnership for Parkinson's Dise60%

see_also📖Cholinergic Hypothesis in Alzheimer's Disease60%

see_also📖Fibrinogen and αVβ3 Integrin in Alpha-Synuclein Pathology60%

see_also📖Glia-Neuron Crosstalk in Alzheimer's Disease60%

see_also📖Glymphatic System in Alzheimer's Disease60%

see_also📖Infectious Etiology Hypotheses in Alzheimer's Disease60%

see_also📖Infectious Triggers in Alzheimer's Disease60%

see_also📖Innate Immune Signaling Pathways in Alzheimer's Disease60%

see_also📖Integrated Stress Response in Alzheimer's Disease60%

see_also📖Microglial State Trajectory from Mobilization to Dysregulati60%

see_also📖mitochondrial-dysfunction-ad60%

see_also📖MLCS Quantification Methods in Parkinson's Disease Rese60%

see_also📖Neuronal Death Pathways in Alzheimer's Disease60%

see_also📖Pallido-Thalamocortical Motor Pathway in Parkinson's Di60%

see_also📖PDLIM7 Epigenetic Activation in Parkinson's Disease60%

see_also📖PKM2 Metabolic Dysregulation in Alzheimer's Disease60%

see_also📖psilocybin-neuropsychiatric-ad60%

see_also📖RNA Metabolism Dysregulation in Alzheimer's Disease60%

see_also📖SAA and Imaging for Prodromal Parkinson's Disease Trial60%

see_also📖Sleep Disruption in Alzheimer's Disease60%

see_also📖Vascular Contributions to Alzheimer's Disease60%

see_also📖Seattle Alzheimer's Disease Brain Cell Atlas (SEA-AD)60%

see_also📖AI-Powered Movement Analysis for Parkinson's Disease60%

see_also📖Digital Biomarker Platforms for Parkinson's Disease60%

see_also📖Digital Therapeutics for Parkinson's Disease60%

see_also📖Wearable Sensors for Parkinson's Disease60%

see_also📖Adenosine A2A Receptor Antagonists60%

see_also📖CAR-A (Chimeric Antigen Receptor) Astrocyte Therapy for Alzh60%

see_also📖CUE1 Non-Invasive Vibrotactile Device for Parkinson's D60%

see_also📖Ferulic Acid Carbamate Derivatives for Alzheimer's Dise60%

see_also📖Neurorestore Therapies for Parkinson's Disease60%

see_also📖Synaptic Plasticity Therapeutics for Parkinson's Diseas60%

see_also📖Dementia with Lewy Bodies Biomarkers60%

see_also📖Dementia with Lewy Bodies Circuit60%

see_also📖Dementia with Lewy Bodies Diagnostic Methods60%

see_also📖Dementia with Lewy Bodies Knowledge Gaps60%

see_also📖ATP1B1 Gene60%

see_also📖atp1b360%

see_also📖DnaJ Heat Shock Protein Family (Hsp40) Member A160%

see_also📖IREB2 — Iron Responsive Element Binding Protein 260%

see_also📖slc22a160%

see_also📖Autoimmune Hypothesis in Alzheimer's Disease60%

see_also📖Dementia Australia60%

see_also📖dementia-discovery-fund60%

see_also📖Dementia with Lewy Bodies Mechanistic Pathway60%

see_also📖Proteins60%

see_also📖ATP1B1 Protein60%

see_also📖DNA Methylation60%

see_also📖Ferroptosis-Sensitive Neurons60%

see_also📖Notch Signaling and Gamma-Secretase Modulators for Alzheimer60%

see_also📖Notch and Gamma-Secretase Modulators for Parkinson's Di60%

see_also📖AMPK (AMP-Activated Protein Kinase)60%

see_also📖Ferroptosis60%

see_also📖Ferroptosis Validation in Parkinson's Disease60%

see_also📖ACE Gene60%

see_also📖APOB Gene60%

see_also📖NOTCH1 Gene60%

see_also📖Ferroptosis Hypothesis in Parkinson's Disease60%

see_also📖Wnt-Beta-Catenin Signaling Dysfunction Hypothesis in Parkins60%

see_also📖AMPK Agonist Therapy for Neurodegeneration60%

see_also📖Ferroptosis Inhibition Therapy60%

see_also📖Notch Signaling Modulation Therapy for Neurodegeneration60%

see_also📖Wnt Pathway Modulation for Synaptic Resilience60%

see_also📖Ferroptosis Modulation Investment Landscape60%

see_also📖Wnt Signaling Therapeutics: Investment Landscape Analysis60%

see_also📖Ferroptosis in Neurodegeneration60%

see_also📖ferroptosis-4r-tauopathies60%

see_also📖Ferroptosis in Alzheimer's Disease60%

see_also📖Ferroptosis Pathway in Alzheimer's Disease60%

see_also📖Ferroptosis in Alzheimer's Disease60%

see_also📖Ferroptosis and Lipid Peroxidation in 4R-Tauopathies60%

see_also📖Ferroptosis in Neurodegeneration60%

see_also📖Ferroptosis Pathway in Neurodegeneration60%

see_also📖Ferroptosis in Parkinson's Disease60%

see_also📖Ferroptosis Pathway in Neurodegeneration60%

see_also📖Notch Signaling in Parkinson's Disease60%

see_also📖Notch Signaling in 4R-Tauopathies60%

see_also📖Notch Signaling Pathway in Neurodegeneration60%

see_also📖Notch Signaling in Parkinson's Disease60%

see_also📖Notch Signaling Pathway in Neurodegeneration60%

see_also📖wnt-beta-catenin-signaling-pathway60%

see_also📖Wnt Non-Canonical Signaling Pathways in Neurodegeneration60%

see_also📖Wnt Signaling in Parkinson's Disease60%

see_also📖WNT Signaling in Neurodegeneration60%

see_also📖Wnt Signaling in 4R-Tauopathies60%

see_also📖Wnt Signaling Dysfunction in Neurodegenerative Diseases60%

see_also📖Wnt Signaling in Neurodegeneration60%

see_also📖Wnt Signaling Pathway in Neurodegeneration60%

see_also📖Notch1 Protein60%

see_also📖Ferroptosis Inhibitors60%

see_also📖Ferroptosis Modulation Therapy60%

see_also📖Ferroptosis Therapy for Parkinson's Disease60%

see_also📖Notch Signaling Modulators for Neurodegeneration60%

see_also📖Wnt Signaling Modulation Therapy60%

see_also📖Wnt Signaling Modulators for Neurodegeneration60%

see_also📖JAK Inhibitors in Parkinson's Disease60%

see_also📖MTOR (Redirect)60%

see_also📖mTOR Signaling Dysregulation in Progressive Supranuclear Pal60%

see_also📖ALDH1A1 Gene60%

see_also📖APC Gene60%

see_also📖ATF3 Gene60%

see_also📖AXIN1 Gene60%

see_also📖AXIN2 Gene60%

see_also📖BCL2 Gene60%

see_also📖BRG1 Gene60%

see_also📖CCL3 Gene60%

see_also📖CD44 - Cell Surface Glycoprotein60%

see_also📖Class II Major Histocompatibility Complex Transactivator60%

see_also📖CREBBP Gene60%

see_also📖ctnnb160%

see_also📖DKK1 — Dickkopf WNT Signaling Pathway Inhibitor 160%

see_also📖DLL1 Gene60%

see_also📖dr560%

see_also📖EP300 Gene60%

see_also📖FGF18 Gene60%

see_also📖FGF20 Gene60%

see_also📖FOXM1 Gene60%

see_also📖fzd760%

see_also📖GAIN Gene - GABA-A Receptor Associated Protein Like 260%

see_also📖IL10 — Interleukin 1060%

see_also📖JAG1 — Jagged 160%

see_also📖LEF160%

see_also📖MITF Gene — Microphthalmia-Associated Transcription Factor60%

see_also📖MTOR Gene60%

see_also📖MYC Gene60%

see_also📖NEUROD1 Gene60%

see_also📖NOTCH2 — Notch Receptor 260%

see_also📖NRCAM Gene60%

see_also📖ppard60%

see_also📖PTGS2 - Prostaglandin-Endoperoxide Synthase 260%

see_also📖SMARCA460%

see_also📖TERT Gene60%

see_also📖VEGFA — Vascular Endothelial Growth Factor A60%

see_also📖JAK-STAT and Cytokine Signaling in 4R-Tauopathies60%

see_also📖JAK-STAT Signaling in Parkinson's Disease60%

see_also📖JAK-STAT Signaling Pathway in Neurodegeneration60%

see_also📖APC Protein60%

see_also📖AXIN1 Protein60%

see_also📖AXIN2 Protein60%

see_also📖BCL2 (B-Cell Lymphoma 2)60%

see_also📖D5 Dopamine Receptor Protein60%

see_also📖MTOR Protein60%

see_also📖Notch2 Protein60%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread55%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration55%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration55%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration55%

see_also📖Endosomal Sorting Defects in Neurodegeneration55%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration55%

see_also📖PPAR Signaling Pathway in Neurodegeneration55%

see_also📖RNA-Targeted Therapies in Neurodegeneration55%

see_also📖Senescent Cell Clearance in Neurodegeneration55%

mentions🧪Arginine Methylation Enhancement Therapy50%

mentions🧪Piezoelectric Nanochannel BBB Disruption50%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration50%

see_also📖Exosomal Biomarkers in Neurodegeneration50%

see_also📖Exosomal miR-155 in Neurodegeneration50%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration50%

see_also📖Liquid Biopsy in Neurodegeneration50%

see_also📖Metabolomic Biomarkers in Neurodegeneration50%

see_also📖Neuroimaging Biomarkers for Neurodegeneration50%

see_also📖Synaptic Biomarkers in Neurodegeneration50%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and50%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI50%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St50%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451650%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl50%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime50%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 50%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)50%

see_also📖China Neurodegeneration Epidemiology50%

see_also📖DALY Methodology — Neurodegeneration50%

see_also📖Disease Progression & Staging in Neurodegeneration50%

see_also📖Economic Burden — Neurodegeneration50%

see_also📖European Neurodegeneration Epidemiology50%

see_also📖Familial vs Sporadic Neurodegeneration Comparison50%

see_also📖Global Neurodegeneration Epidemiology50%

see_also📖India Neurodegeneration Epidemiology50%

see_also📖Japan Neurodegeneration Epidemiology50%

see_also📖Manganese-Related Neurodegeneration (Manganism)50%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison50%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr50%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 50%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)50%

see_also📖Potential Impact Measures — Neurodegeneration50%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)50%

see_also📖Sleep Disorders in Neurodegeneration50%

see_also📖US Neurodegeneration Epidemiology50%

see_also📖acetylcholine-signaling-neurodegeneration50%

see_also📖Advanced Glycation End Products in Neurodegeneration50%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 50%

see_also📖Amylin Signaling in Neurodegeneration50%

see_also📖Antibody Therapy in Neurodegeneration50%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration50%

see_also📖Autosis Pathway in Neurodegeneration50%

see_also📖Axon Guidance Pathways in Neurodegeneration50%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration50%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain50%

see_also📖CaMKII Signaling Pathway in Neurodegeneration50%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration50%

see_also📖Cholinergic System Dysfunction in Neurodegeneration50%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat50%

see_also📖Neural Circuits in Neurodegeneration50%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration50%

see_also📖Computational Disease Models for Neurodegeneration50%

see_also📖Convergent Pathways in Neurodegeneration50%

see_also📖Copper Homeostasis in Neurodegeneration50%

see_also📖COVID-19 Neurodegeneration Mechanism50%

see_also📖Diffusion MRI (DTI) in Neurodegeneration50%

see_also📖Digital Phenotyping in Neurodegeneration50%

see_also📖Down Syndrome Neurodegeneration Pathway50%

see_also📖Dystrophic Neurites in Neurodegeneration50%

see_also📖Endocannabinoid System in Neurodegeneration50%

see_also📖Endothelin Signaling Pathway in Neurodegeneration50%

see_also📖epigenetics-neurodegeneration50%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration50%

see_also📖FA2H-Associated Neurodegeneration Pathway50%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration50%

see_also📖Galectin-3 Mechanism in Neurodegeneration50%

see_also📖Gangliosides in Neurodegeneration50%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration50%

see_also📖GDNF Signaling Pathway in Neurodegeneration50%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration50%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration50%

see_also📖Glycosylation in Neurodegeneration50%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration50%

see_also📖Hippocampal Neurogenesis in Neurodegeneration50%

see_also📖Histone Modification Pathways in Neurodegeneration50%

see_also📖HMGB1 Signaling in Neurodegeneration50%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration50%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration50%

see_also📖IL-1 Signaling Pathway in Neurodegeneration50%

see_also📖Integrated Stress Response in Neurodegeneration50%

see_also📖interleukin-6-signaling-neurodegeneration50%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration50%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 50%

see_also📖Kidney-Brain Neurodegeneration Axis50%

see_also📖Lipid Dysregulation in Neurodegeneration50%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration50%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration50%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration50%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration50%

see_also📖Metal Homeostasis in Neurodegeneration50%

see_also📖Microglial Priming Pathway in Neurodegeneration50%

see_also📖MicroRNA Dysfunction in Neurodegeneration50%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration50%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration50%

see_also📖Mitochondrial Fusion in Neurodegeneration50%

see_also📖Molecular Chaperones in Neurodegeneration50%

see_also📖mTOR Signaling in Neurodegeneration50%

see_also📖mTOR Signaling Pathway in Neurodegeneration50%

see_also📖Neural Circuit Disruption in Neurodegeneration50%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N50%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati50%

see_also📖Neuronal Hyperexcitability in Neurodegeneration50%

see_also📖Neuropil Threads in Neurodegeneration50%

see_also📖Neurotensin Signaling in Neurodegeneration50%

see_also📖NF-kB Signaling Pathway in Neurodegeneration50%

see_also📖Nitric Oxide Signaling in Neurodegeneration50%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration50%

see_also📖Neuropeptide Y Signaling in Neurodegeneration50%

see_also📖NRF2 Signaling Pathway in Neurodegeneration50%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration50%

see_also📖Orexin Signaling in Neurodegeneration50%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration50%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration50%

see_also📖Paranodal Dysfunction in Neurodegeneration50%

see_also📖Paraptosis in Neurodegeneration50%

see_also📖Parthanatos in Neurodegeneration50%

see_also📖Pericyte Loss in Neurodegeneration50%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration50%

see_also📖PKR Pathway in Neurodegeneration50%

see_also📖Prion Diseases in Neurodegeneration50%

see_also📖Prion-Like Spread in Neurodegeneration50%

see_also📖Prion Protein Metabolism in Neurodegeneration50%

see_also📖Progesterone Signaling Pathway in Neurodegeneration50%

see_also📖Prognostic Biomarkers in Neurodegeneration50%

see_also📖Protein Aggregation Comparison in Neurodegeneration50%

see_also📖Protein Aggregation Seeds in Neurodegeneration50%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration50%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su50%

see_also📖Purinergic Signaling in Neurodegeneration50%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener50%

see_also📖R-Loop Stress in Neurodegeneration50%

see_also📖RAN Translation in Neurodegeneration50%

see_also📖Retinal Degeneration Pathway in Neurodegeneration50%

see_also📖Ribosome Dysfunction in Neurodegeneration50%

see_also📖RNA Splicing in Neurodegeneration50%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a50%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration50%

see_also📖Serotonergic Dysfunction in Neurodegeneration50%

see_also📖Sex Differences in Neurodegeneration50%

see_also📖Short Chain Fatty Acids in Neurodegeneration50%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration50%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration50%

see_also📖Sleep Dysfunction in Neurodegeneration50%

see_also📖SUMOylation in Neurodegeneration50%

see_also📖synaptic-vesicle-cycling-neurodegeneration50%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration50%

see_also📖T-Cell Dysfunction in Neurodegeneration50%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration50%

see_also📖Therapeutic Targets in Neurodegeneration50%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration50%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration50%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration50%

see_also📖Vagus Nerve Pathway in Neurodegeneration50%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio50%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio50%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen50%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration50%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE45%

see_also📖APOE4 (Apolipoprotein E4)45%

see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas45%

see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc45%

see_also📖SNCA — Alpha-Synuclein Gene Entity Page45%

see_also📖Alzheimer's Disease Mechanism Index45%

see_also📖NLRP3 Inflammasome Inhibitors for Parkinson's Disease45%

mentions🔬What are the mechanisms underlying rna binding protein dysre40%

mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction40%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD40%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

related🧪APOE Isoform Conversion Therapy40%

related🧪Aquaporin-4 Polarization Rescue40%

related🧪PARP1 Inhibition Therapy40%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t35%